Development and validation of a general population renal risk score

N. Halbesma; D.F. Jansen; M.W. Heijmans; R.P Stolk; P.E. de Jong; R.T. Gansevoort

doi:https://doi.org/10.2215/CJN.08590910

Development and validation of a general population renal risk score

N. Halbesma, D.F. Jansen, M.W. Heijmans, R.P Stolk, P.E. de Jong, R.T. Gansevoort

Epidemiology and Data Science (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

75 Citations (Scopus)

Abstract

Background and objectives There is a need for prediction scores that identify individuals at increased risk for developing progressive chronic kidney disease (CKD). Therefore, this study was performed to develop and validate a "renal risk score" for the general population. Design, setting, participants, & measurements For this study we used data from the PREVEND (Prevention of Renal and Vascular ENdstage Disease) study, a prospective population-based cohort study with a median follow-up of 6.4 years. Participants with two or three consecutive estimated GFR (eGFR) measurements during follow-up were included. Participants within the group who had the most renal function decline (top 20% of the total population) and had an eGFR value <60 ml/min per 1.73 m

Original language	English
Pages (from-to)	1731-1738
Journal	Clinical journal of the American Society of Nephrology
Volume	6
Issue number	7
DOIs	https://doi.org/10.2215/CJN.08590910
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://doi.org/10.2215/CJN.08590910

Cite this

@article{ab30cda6401045ea9b9eab15d68458d3,

title = "Development and validation of a general population renal risk score",

abstract = "Background and objectives There is a need for prediction scores that identify individuals at increased risk for developing progressive chronic kidney disease (CKD). Therefore, this study was performed to develop and validate a {"}renal risk score{"} for the general population. Design, setting, participants, & measurements For this study we used data from the PREVEND (Prevention of Renal and Vascular ENdstage Disease) study, a prospective population-based cohort study with a median follow-up of 6.4 years. Participants with two or three consecutive estimated GFR (eGFR) measurements during follow-up were included. Participants within the group who had the most renal function decline (top 20% of the total population) and had an eGFR value <60 ml/min per 1.73 m",

author = "N. Halbesma and D.F. Jansen and M.W. Heijmans and R.P Stolk and {de Jong}, P.E. and R.T. Gansevoort",

note = "group authors: PREVEND Study Group",

year = "2011",

doi = "https://doi.org/10.2215/CJN.08590910",

language = "English",

volume = "6",

pages = "1731--1738",

journal = "Clinical journal of the American Society of Nephrology",

issn = "1555-9041",

publisher = "American Society of Nephrology",

number = "7",

}

TY - JOUR

T1 - Development and validation of a general population renal risk score

AU - Halbesma, N.

AU - Jansen, D.F.

AU - Heijmans, M.W.

AU - Stolk, R.P

AU - de Jong, P.E.

AU - Gansevoort, R.T.

N1 - group authors: PREVEND Study Group

PY - 2011

Y1 - 2011

N2 - Background and objectives There is a need for prediction scores that identify individuals at increased risk for developing progressive chronic kidney disease (CKD). Therefore, this study was performed to develop and validate a "renal risk score" for the general population. Design, setting, participants, & measurements For this study we used data from the PREVEND (Prevention of Renal and Vascular ENdstage Disease) study, a prospective population-based cohort study with a median follow-up of 6.4 years. Participants with two or three consecutive estimated GFR (eGFR) measurements during follow-up were included. Participants within the group who had the most renal function decline (top 20% of the total population) and had an eGFR value <60 ml/min per 1.73 m

AB - Background and objectives There is a need for prediction scores that identify individuals at increased risk for developing progressive chronic kidney disease (CKD). Therefore, this study was performed to develop and validate a "renal risk score" for the general population. Design, setting, participants, & measurements For this study we used data from the PREVEND (Prevention of Renal and Vascular ENdstage Disease) study, a prospective population-based cohort study with a median follow-up of 6.4 years. Participants with two or three consecutive estimated GFR (eGFR) measurements during follow-up were included. Participants within the group who had the most renal function decline (top 20% of the total population) and had an eGFR value <60 ml/min per 1.73 m

U2 - https://doi.org/10.2215/CJN.08590910

DO - https://doi.org/10.2215/CJN.08590910

M3 - Article

C2 - 21734089

SN - 1555-9041

VL - 6

SP - 1731

EP - 1738

JO - Clinical journal of the American Society of Nephrology

JF - Clinical journal of the American Society of Nephrology

IS - 7

ER -